AzTrials
AzTrials

Dynamic Balance in Asymptomatic Young AdultsSNBTNCT07918703

Immediate Effect of Slump Neural Tensioners Compared With Neural Sliders on Dynamic Balance in Asymptomatic Young Adults

A study testing Slump Neural Slider Technique and Slump Neural Tensioner Technique in people with Dynamic Balance in Asymptomatic Young Adults, run by Gulf Medical University at 1 site in United Arab Emirates.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this interventional study is to learn if slump neural tensioner and slump neural slider techniques can immediately improve dynamic balance in asymptomatic healthy young adults aged 18-25 years. Read more about this study

Who is it for?
Ages 18 to 25 yearsHealthy volunteers can take part
What is being tested?
Slump Neural Slider Technique and Slump Neural Tensioner Technique
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteUnited Arab Emirates
Study dates
30 Jul 2026to 7 Aug 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • • Age between 18 and 25 years
  • Both male and female participants
  • Healthy individuals with no current musculoskeletal pain or neurological symptoms
  • Ability to perform the slump sitting position
  • Willingness to provide written informed consent

Who cannot join

  • • Diagnosed neurological disorders (e.g., peripheral neuropathy, multiple sclerosis) (39).
  • Recent musculoskeletal injury or surgical history within the past six months (40).
  • Diagnosed vestibular dysfunction or balance disorders (41).
  • Lower limb deformity or congenital abnormalities affecting gait or posture (39)
  • Active musculoskeletal pain or discomfort (NRS ≥ 1/10) (42)
  • Any condition contraindicating neural mobilization (e.g., malignancy, fractures, acute infection)

Trial locations and contacts

1 site in 1 country.

United Arab Emirates1 site
  • Dr Watson Arulsingh

    Ajman, Ajman Emirate

Other trials in United Arab Emirates

About this study

The goal of this interventional study is to learn if slump neural tensioner and slump neural slider techniques can immediately improve dynamic balance in asymptomatic healthy young adults aged 18-25 years. The main questions it aims to answer are:

Does the slump neural tensioner technique produce greater immediate improvement in dynamic balance compared to the slump neural slider technique? Do both techniques improve Y Balance Test scores immediately after a single session of treatment?

Read more

Researchers will compare the slump neural tensioner group to the slump neural slider group to see if one technique produces a greater immediate effect on dynamic balance.

Participants will:

Be randomly assigned to receive either the slump neural slider or the slump neural tensioner technique in a single session Perform 10 repetitions of their assigned technique for 3 sets in the slump sitting position Have their dynamic balance measured using the Lower Quarter Y Balance Test before and immediately after the intervention Complete the entire session in approximately 30-45 minutes in one visit only

Read the detailed description

BACKGROUND Dynamic balance is a fundamental sensorimotor function required for safe and efficient movement during daily activities, sports, and rehabilitation. It depends on the continuous integration of proprioceptive, vestibular, and visual inputs with appropriate neuromuscular responses. Restrictions in neural tissue mobility - even in asymptomatic individuals - may impair afferent proprioceptive signaling from mechanoreceptors distributed along the peripheral neural pathway, potentially degrading neuromuscular coordination and dynamic balance performance.

Neural mobilization (NM) is a movement-based physiotherapy intervention designed to restore normal neural tissue mechanics and physiology. It comprises two primary techniques: the neural slider, which promotes nerve excursion through alternating opposite-direction joint movements with minimal neural strain; and the neural tensioner, which applies controlled mechanical loading through simultaneous same-direction joint movements to improve the viscoelastic properties of neural tissues. Both techniques are performed in the slump sitting position - a standardized posture that effectively loads the posterior neuromeningeal tract and sciatic nerve - making it optimal for lower limb neurodynamic interventions.

While existing evidence confirms that both techniques improve hamstring flexibility and reduce neural mechanosensitivity, their comparative immediate effects on dynamic balance in asymptomatic young adults remain unclear. Most prior studies have focused on symptomatic populations, making it difficult to isolate the pure neurodynamic contribution to balance from the confounding effects of pain relief. The present study was designed to address this gap.

STUDY DESIGN This is a two-arm parallel-group randomized controlled trial. Participants are randomly allocated in a 1:1 ratio to one of two intervention groups using a computer-generated randomization sequence prepared by an independent researcher not involved in data collection. Allocation concealment is maintained using sequentially numbered, sealed opaque envelopes opened immediately prior to the intervention session.

SETTING The study is conducted at the Physiotherapy Laboratory, College of Health Sciences, Gulf Medical University, Ajman, United Arab Emirates. All assessments and interventions are performed in the same standardized laboratory environment to minimize environmental confounding.

PARTICIPANTS One hundred asymptomatic young adults aged 18-25 years are recruited from Gulf Medical University and the surrounding community using convenience sampling. Eligibility is confirmed through clinical screening, the Nordic Musculoskeletal Questionnaire (NMQ), and physical assessment prior to enrollment.

Inclusion Criteria:

Age 18-25 years Male or female Healthy with no current musculoskeletal pain or neurological symptoms Able to assume and maintain the slump sitting position Willing to provide written informed consent

Exclusion Criteria:

Diagnosed neurological disorders Musculoskeletal injury or surgery within the past 6 months Vestibular dysfunction or balance disorders Lower limb deformity or congenital abnormalities Active musculoskeletal pain (NRS > 0/10) Any contraindication to neural mobilization

BASELINE ASSESSMENTS

Prior to randomization, all participants undergo the following standardized assessments performed by a trained physiotherapist:

Demographic and anthropometric data: age, gender, height, weight, body mass index (BMI) Nordic Musculoskeletal Questionnaire (NMQ) for musculoskeletal symptom screening International Physical Activity Questionnaire - Short Form (IPAQ-SF) for physical activity level classification Leg length measurement: anterior superior iliac spine (ASIS) to medial malleolus using a measuring tape Foot length measurement: heel to longest toe using a standardized measuring scale Hamstring length: Active Knee Extension Test (90-90 test) using a universal goniometer (ICC > 0.90) Knee range of motion: universal goniometer Ankle dorsiflexion range of motion: universal goniometer

Primary Outcome - Lower Quarter Y Balance Test (YBT-LQ):

Dynamic balance is assessed using the Lower Quarter Y Balance Test in three reach directions: anterior (ANT), posteromedial (PM), and posterolateral (PL). Participants stand on the test limb on a central platform and reach maximally with the contralateral limb in each direction. Three practice trials are performed to minimize learning effects, followed by three recorded trials per direction. Reach distances are measured in centimetres, normalized to leg length, and averaged across three trials. A composite score is calculated as the mean of the three normalized reach distances multiplied by 100. The YBT-LQ demonstrates high reliability (ICC = 0.85-0.99) and predictive validity for lower extremity injury risk.

INTERVENTIONS Both interventions are administered by the same trained physiotherapist following a standardized written protocol. All participants are positioned in the slump sitting posture: thoracic and lumbar spine in full flexion, hands clasped behind the back, hips flexed to 90 degrees, knees flexed to approximately 90 degrees, and ankles in neutral position.

Group A - Slump Neural Slider Technique:

The participant actively performs cervical spine extension combined with knee extension and ankle dorsiflexion, followed by cervical spine flexion combined with knee flexion and ankle relaxation. This alternating movement promotes bidirectional neural excursion along the posterior kinetic chain with minimal increase in neural strain. The end position is held for 2 seconds before returning to the starting position. The movement is performed slowly and in a controlled manner at approximately 4 seconds per repetition. The technique is administered for 10 repetitions per set, 3 sets, with 30-second rest intervals between sets. Total intervention time is approximately 3-4 minutes. The intervention is stopped immediately if the participant reports pain greater than 3/10, numbness, tingling, dizziness, or cramping.

Group B - Slump Neural Tensioner Technique:

The participant maintains the cervical spine in sustained flexion while simultaneously performing active knee extension and ankle dorsiflexion, progressively increasing mechanical loading along the entire posterior neuromeningeal pathway. The end position is held for 2-3 seconds before returning to the starting position. Movements are slow and controlled at approximately 4-5 seconds per repetition. The technique is administered for 10 repetitions per set, 3 sets, with 30-second rest intervals between sets. Total intervention time is approximately 3-4 minutes. The intervention is stopped immediately if the participant reports pain greater than 3/10, numbness, tingling, dizziness, or excessive neural discomfort.

POST-INTERVENTION ASSESSMENT Immediately following the completion of the assigned intervention, dynamic balance is reassessed using the Lower Quarter Y Balance Test following the identical standardized procedure used at baseline. Reach distances in the anterior, posteromedial, and posterolateral directions are recorded as post-intervention outcome values.

SAMPLE SIZE The sample size was calculated based on the two-sample independent t-test formula for comparison of two independent groups. Assuming a two-tailed alpha of 0.05, 80% statistical power, a clinically meaningful between-group difference of 5 points in the YBT composite score, and a pooled standard deviation of approximately 8 points derived from pilot data and prior literature, the required sample size is approximately 44 participants per group. This was increased to 50 per group (total n = 100) to account for a 10-12% dropout rate commonly observed in similar single-session intervention studies, ensuring adequate statistical power for robust inference.

STATISTICAL ANALYSIS PLAN

All data are entered and analyzed using IBM SPSS Statistics software (Version 28). The following analytical approach is employed:

Descriptive Statistics: Mean and standard deviation for continuous variables; frequency and percentage for categorical variables. Used to summarize baseline demographic and anthropometric characteristics of both groups.

Normality Testing: Shapiro-Wilk test applied to all continuous outcome variables prior to inferential analysis.

Within-Group Analysis: Paired samples t-test used to compare pre- and post-intervention YBT reach distances (ANT, PM, PL, and composite score) within each group separately.

Between-Group Analysis: Independent samples t-test used to compare the magnitude of change (post minus pre) in YBT scores between Group A (Neural Slider) and Group B (Neural Tensioner).

Effect Size: Cohen's d calculated for all significant comparisons to quantify the practical significance of observed differences.

Side-to-Side Asymmetry: Paired t-test used to evaluate limb asymmetry in YBT reach distances before and after the intervention within each group.

Level of Significance: p < 0.05 is considered statistically significant for all analyses.

PLAN FOR MISSING DATA Given the single-session design of this study, missing data are not anticipated. However, should any participant be unable to complete the post-intervention YBT assessment due to discomfort or withdrawal, their data will be excluded from the analysis and documented as a protocol deviation. No imputation methods will be applied. All withdrawals and reasons for missing data will be reported transparently in the final manuscript.

DATA MANAGEMENT AND QUALITY ASSURANCE All data are recorded on pre-designed, standardized paper-based data collection forms at the time of assessment. Data are subsequently entered into password-protected electronic spreadsheets by the principal investigator. A second team member independently verifies 100% of entered data against source documents to identify and correct transcription errors. Both hard copy and electronic copies of all data are stored securely at Gulf Medical University for a minimum of three years following study completion, accessible only to the authorized research team. No personal identifiers are included in the analysis dataset; participants are identified by unique numeric codes only.

ETHICAL CONSIDERATIONS The study has received ethical approval from the Gulf Medical University Institutional Review Board (GMU-IRB). All participants provide written informed consent prior to enrollment. Participation is entirely voluntary and participants may withdraw at any time without consequence. Confidentiality is maintained throughout by replacing personal identifiers with participant codes in all records and publications.

Being tested
Slump Neural Slider Technique, Slump Neural Tensioner Technique
Keywords
Neural Mobilization, Neural Slider, Neural Tensioner, Neurodynamics, Dynamic Balance, Postural Control, Y Balance Test, Slump Position, Hamstring Flexibility, Neuromuscular Control

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Slump Neural Slider TechniqueOther

    Performed in slump sitting with thoracic and lumbar flexion, hips at 90 degrees. Cervical extension with knee extension and ankle dorsiflexion, then return. End position held 2 seconds. 10 repetitions, 3 sets, 30 second rest. Total 3 to 4 minutes.

  • Slump Neural Tensioner TechniqueOther

    Performed in slump sitting with thoracic and lumbar flexion, hips at 90 degrees. Sustained cervical flexion with simultaneous knee extension and ankle dorsiflexion. End position held 2 to 3 seconds. 10 repetitions, 3 sets, 30 second rest. Total 3 to 4 minutes.

Study groups in NCT07918703
Study groupRoleWhat they receive
Slump Neural Slider GroupActive comparatorParticipants receive the slump neural slider technique in slump sitting position. Cervical extension combined with knee extension and ankle dorsiflexion, then cervical flexion with knee flexion. 10 repetitions per set, 3 sets, 30 second rest between sets.
Receives: Other: Slump Neural Slider Technique
Slump Neural Tensioner GroupExperimentalParticipants receive the slump neural tensioner technique in slump sitting position. Sustained cervical flexion with simultaneous knee extension and ankle dorsiflexion. 10 repetitions per set, 3 sets, 30 second rest between sets.
Receives: Other: Slump Neural Tensioner Technique

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in normalized Y-Balance Test composite scores from baseline to immediately and 20 min after intervention

    Dynamic balance was assessed using the Lower Quarter Y-Balance Test for the right and left lower limbs. For each limb, the composite score was calculated as [(anterior + posteromedial + posterolateral reach distances)/(3 × limb length)] × 100 and expressed as percentage of limb length. Changes from baseline to immediately after intervention were compared between the slump neural slider and slump neural tensioner groups. Higher scores indicate better dynamic balance.

    Measured: Baseline and immediately after a single intervention session.

Secondary outcomes (4)
  1. Change in hamstring flexibility measured using the Active Knee Extension test

    Hamstring flexibility was assessed in the right and left lower limbs using the Active Knee Extension test. Knee extension range was recorded in degrees. Changes from baseline to immediately after intervention were assessed within each group.

    Measured: Baseline and immediately after a single intervention session.

  2. Change in ankle dorsiflexion range of motion

    Ankle dorsiflexion range of motion was measured in degrees for the right and left lower limbs. Changes from baseline to immediately after intervention were assessed within each group.

    Measured: Baseline and immediately after a single intervention session.

  3. Change in ankle plantarflexion range of motion

    Ankle plantarflexion range of motion was measured in degrees for the right and left lower limbs. Changes from baseline to immediately after intervention were assessed within each group.

    Measured: Baseline and immediately after a single intervention session.

  4. Change in knee range of motion

    Knee range of motion was measured in degrees for the right and left lower limbs. Changes from baseline to immediately after intervention were assessed within each group.

    Measured: Baseline and immediately after a single intervention session.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Nov 2026
  2. Study start30 Jul 2026
  3. Primary completion7 Aug 2026
  4. Study completion7 Aug 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07918703
Sponsor's protocol ID
IRB-COHS-STD-170-May-2026
Other IDs
IRB-COHS-STD-170-May-2026
Acronym
SNBT
Status last verified
Nov 2026
First submitted
1 Nov 2026
Last updated
5 Nov 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: "Individual participant data will not be shared. Study findings will be reported in aggregate form in publications and presentations

Questions about this trial

What is this clinical trial studying?

A study testing Slump Neural Slider Technique and Slump Neural Tensioner Technique in people with Dynamic Balance in Asymptomatic Young Adults, run by Gulf Medical University at 1 site in United Arab Emirates.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Arab Emirates. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in normalized Y-Balance Test composite scores from baseline to immediately and 20 min after intervention (time frame: Baseline and immediately after a single intervention session.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in